![Divestment_HeroImage.jpg](https://www.hcp.novartis.ie/sites/hcp.novartis.ie/files/styles/article_image/public/Divestment_Hero_Image.jpg?itok=LOwWmISo)
Biosimilars
Hospital Brands
Retail Brands
Rate this content:
March 2023 | IE270617
×
Ask Speakers
×
Medical Information Request
Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.